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Abstract 
Rodents, in particular Mus musculus, have a long and invaluable history as models for human 
diseases in biomedical research, although their translational value has been challenged in a 
number of cases. We provide some examples in which rodents have been suboptimal as 
models for human biology and discuss confounders which influence experiments and may 
explain some of the misleading results. Infections of rodents with protozoan parasites are no 
exception in requiring close consideration upon model choice. We focus on the significant 
differences between inbred, outbred and wild animals, and the importance of factors such as 
microbiota, which are gaining attention as crucial variables in infection experiments. 
 
Frequently, mouse or rat models are chosen for convenience, e.g., availability in the 
institution rather than on an unbiased evaluation of whether they provide the answer to a 
given question. Apart from a general discussion on translational success or failure, we provide 
examples where infections with single-celled parasites in a chosen lab rodent gave 
contradictory or misleading results, and when possible discuss the reason for this. We present 
emerging alternatives to traditional rodent models, such as humanized mice and organoid 
primary cell cultures. So-called recombinant inbred strains such as the Collaborative Cross 
collection are also a potential solution for certain challenges. In addition, we emphasize the 
advantages of using wild rodents for certain immunological, ecological and/or behavioral 
questions. The experimental challenges (e.g. availability of species-specific reagents) that 
come with the use of such non-model systems are also discussed. Our intention is to foster 
critical judgment of both traditional and newly available translational rodent models for 
research on parasitic protozoa that can complement the existing mouse and rat models. 
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1 Introduction 
Gregor Mendel introduced the basic concept of a “model organism” when he reported his 
experiments on plant hybrids. He picked peas as a model because they had clear experimental 
advantages for addressing his question: “At the very outset special attention was devoted to 
the Leguminosae on account of their peculiar floral structure (...) this led to the result that the 
genus Pisum was found to possess the necessary qualifications.” (Mendel, 1866) Since then 
this approach for model selection for a particular purpose is widely used, meaning that a 
model organism should be accessible, experimentally tractable, have short generation times, 
be affordable to maintain and breed, possess clearly identifiable features that are to be studied, 
and more recently be genetically tractable (which includes access to a sequenced genome), to 
name a few (Rand, 2008). Given the importance of model systems in biology, the history and 
diversity of model organisms has been extensively reviewed (Conn, 2008; Hunter, 2008; 
Müller and Grossniklaus, 2010; Ankeny and Leonelli, 2011; Bolker, 2012; Alfred and 
Baldwin, 2015). 
 
The available model organisms span a great taxonomic range, and for many questions single-
celled organisms such as bacteria (Escherichia coli) or yeasts (Saccharomyces cerevisiae) are 
sufficient. However, in many biomedical studies which aim to translate findings to humans, 
non-mammals are not applicable as translational models (Hau, 2008). Yet, shorter 
phylogenetic distances and anatomical similarities are no guarantee for translational success, 
as research on primates has demonstrated (detailed in section 4.2).  Given the high relevance 
of protozoa for human and animal health and our own scientific interests in these parasites, 
we will concentrate on such infections in rodents. While their value as translational models is 
not without dispute (see section 2) they have been, still are, and will continue to be, invaluable 
for both basic biological questions in host-parasite interactions as well as pre-clinical studies. 
Their importance for scientific progress is demonstrated, for example by the essential role 
laboratory mice played in the discovery of dendritic cells (see references in Steinman, 2012) 
and macrophages (reviewed by Gordon, 2007). The value of rodents, and mice in particular, 
has also been highlighted for leading to fundamental insights in infection biology (Buer and 
Balling, 2003; Vidal et al., 2008; Douam et al., 2015). Given the historical and current 
importance of rodents, here we explore benefits and limitations of, e.g., inbred or outbred 
mice; lab rodents, or rodents from the wild, etc., as well as possible external confounders, 
such as breeding conditions in lab facilities or interactions in an ecosystem, that might have 
great impact on research results. With this review, we encourage experimentalists, particularly 
in translational medicine, to consider a broad set of potential rodent models in order to 
identify and use the best available system for specific studies. We aim to provide a foundation 
and useful references for such decisions. 
 
2 Protozoan parasites 
Infections with protozoan parasites cause substantial illness and economic loss in humans 
worldwide (see Tables 1 and 2 for details; Fletcher et al., 2012; Murray et al., 2012; Andrews 
et al., 2014; Robertson et al., 2014; Kassebaum et al., 2016). These parasites with high impact 
on humans mostly are the Amoeba, e.g., Entamoeba spp.; the flagellates, e.g., Trichomonas 
spp., Giardia spp., Leishmania spp. and Trypanosoma spp., and the large group of 
Apicomplexans, which contain, e.g., Plasmodium spp., Toxoplasma gondii, and 
Cryptosporidium spp. They are most often transmitted to their host either via ingestion of 
contaminated food, water, or via a vector (e.g. mosquitoes or flies; see Table 2). Here we 
provide a brief overview of some parasitic protozoa which substantially impact humans, and 
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of which many are referred to in our examples used in following sections. 
 
The significance of protozoan infections for global human health is here exemplified by data 
(see Table 1) where the impact of infections by the most devastating protozoan parasites is 
expressed as “disability-adjusted life-years” (DALYs, used by the World Health Organisation 
(WHO) and others as a measure of disease impact). These diseases ranked second in 
importance across all infectious diseases, behind lower respiratory infections, and before 
AIDS and tuberculosis. The great majority of this impact can be attributed to malaria alone 
(caused by Plasmodium spp., 85%). However, the collective disease burden of the other 
protozoa evaluated was also substantial and in the range of influenza (Murray et al., 2012). 
While many of these figures, including those for malaria, are fortunately on the decline, this 
disease was still ranked among the top 20 leading diseases as identified by the WHO 
worldwide in 2015 (Kassebaum et al., 2016). In addition to these human health concerns, 
protozoan parasites cause significant losses in many species of domestic animals (Perry and 
Grace, 2009; Torgerson and Macpherson, 2011; Fitzpatrick, 2013; Torgerson, 2013) and are 
in some cases a conservation concern for wildlife (Pedersen et al., 2007). 
 
While many of these parasites have a very restricted host range (infecting a single host species 
and/or tissue), other extremes such as T. gondii, a zoonotic parasite assumed to infect all 
nucleated cells in all warm-blooded animals, exist. Consequently, there is a mixture of more 
or less natural relationships between the parasites and the rodent hosts when the latter are used 
as translational models for human infections (see Table 2). Many parasite genera contain 
species which naturally infect rodents (e.g. Plasmodium, Giardia, Cryptosporidium), although 
in most cases the very same species do not also infect humans. For other parasite species, the 
rodent model has been made susceptible, frequently by genetic means, to human relevant 
parasites (e.g. P. falciparum or C. parvum/C. hominis). In malaria research, rodents have been 
successfully used as models, but the suitability of the mouse to mimic severe human malaria 
has been questioned (Langhorne et al., 2011). In leishmaniasis research, rodents are 
acknowledged for contributing to a better understanding of the immune response to the 
parasite (Lipoldová and Demant, 2006) but other authors point out limitations and the lack of 
suitability of certain mouse strains to study specific parasite genotypes (Mears et al., 2015). 
Research on human sleeping sickness (T. brucei) has benefitted largely from mouse models 
(Antoine-Moussiaux et al., 2008; Giroud et al., 2009; Magez and Caljon, 2011) but criticism 
has been raised that more suitable animal models should be applied to address sleeping 
sickness in livestock (T. congolense and T. vivax; Morrison et al., 2016). 
  
3 Why are mice and rats such popular models? 
Biomedical research depends heavily on model organisms and the majority of these are 
rodents, particularly in infectious disease and immunological research. A few numbers 
illustrate this impressively. For example, in the European Union alone, 75% of all animals 
used for “experimental and other scientific purposes” in 2011 were house mice (Mus spp., 
61%) and rats (Rattus spp., 14%; The Commission to the Council and the European 
Parliament, 2013). Other rodents (gerbils, hamsters, different species of mice, and other 
rodents) only constitute 0.47% of animals used (Fig. 1A). In Germany, 91.5% of animals used 
in research on infectious diseases were rodents, with the vast majority being Mus musculus 
(88.6%; Fig. 1B). Similar numbers are reported in the United Kingdom, with 82% of all 
research using rodents, again dominated by M. musculus (74.6%; UK Home Office, 2015). 
While these numbers also include animals that were used as donors, e.g., for blood or organs 
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and thus for in vitro experimentation these data nevertheless illustrate the dominance and 
importance of rodents, in particular laboratory inbred mice, as model organisms. 
 
Another informative figure shows that the number of publications where mice and rats were 
mentioned in the title dominates all other model organisms included (Fig. 2), e.g. Arabidopsis, 
Drosophila, S. cerevisiae, Caenorhabditis elegans, Xenopus, zebrafish, Neurospora, and 
Dictyostelium discoideum. It is presumably no coincidence that a sharp increase in these 
“mouse publications” was seen in the 1990s, given that it is when embryonic stem cell 
manipulation met homologous recombination of the mouse genome. This resulted in the 
generation of defined gene knock-out mice (Fig. 2), a finding which was later rewarded with 
the Nobel Prize in Physiology (Mak, 2007). The importance of this discovery for scientific 
progress in infection biology cannot be overestimated. However, in rats no such methods were 
available until relatively recently (Tong et al., 2010; van Boxtel and Cuppen, 2010), which is 
reflected in the drastic increase of mouse models and a relatively stable use of rats from 1990s 
until now. It is likely due to the highly developed genetic tools in mice, together with the 
more than 450 inbred mouse strains established since the first strain (DBA/2) was developed 
by Clarence Cook Little, that mice, and in particular the C57BL/6 strain, are the most popular 
animal model (Beck et al., 2000; Festing and Fisher, 2000). However, with the advent of 
CRISPR/Cas9 gene modifications this will likely change (Hu et al., 2013; Li et al., 2013a; Li 
et al., 2013b), since this method has worked so far in almost all organisms tried and it can 
most likely also be applied to wild rodents. The historic establishment of tools for mice 
combined with the fact that 99% of genes are conserved between the human and the mouse 
genomes (Waterston et al., 2002) has made and will continue to make the mouse an obvious 
choice for translational efforts, i.e., research to understand the basics of and find treatments 
for human diseases. In addition, it will be exciting to see contributions from so far poorly 
explored model systems. 
 
3.1 The mice we use in experiments – who are they and how do they live? 
Here we will briefly cover definitions of nomenclature for referring to different types of mice, 
from laboratory to “wild” rodents. 
 
Classical inbred mice are defined as either being "produced using at least 20 consecutive 
generations of sister x brother or parent x offspring matings” or “traceable to a single ancestral 
pair in the 20th or subsequent generation." (“Nomenclature of Inbred Mice”, defined by the 
Mouse Genomic Nomenclature Committee). However, it can be noted that 20 generations of 
inbreeding does not lead to fixed alleles in the entire genome, although for most phenotypes 
no differences are detected after this threshold (Chia et al., 2005). Different inbred 
populations exist and are referred to as strains (whereas outbred populations are often referred 
to as stocks). Inbred strains are genetically highly homogenous, well-defined, and often with 
genomes and SNP data available. In addition, extensive descriptions of (mutant) strains are 
available in the Mouse Phenome Database (Grubb et al., 2014) or the International Mouse 
Phenotyping Consortium database (Koscielny et al., 2014; see SI Table 1 for links) and 
should be consulted when planning experiments.   
 
Wild-derived inbred strains are “descendants of mice captured in wild populations during 
the mid to late 20th century and represent several different Mus species from around the 
world” (Lutz et al., 2012). These mice are considered suitable for, e.g., evolutionary studies 
and gene mapping, but notably do not represent the genetic diversity of wild animals. 
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Outbred stocks are defined as "a closed population (for at least four generations) of 
genetically variable animals that is bred to maintain maximum heterozygosity" (Chia et al., 
2005), meaning that each individual is genetically different from the others. Once established, 
the goal is to keep the genetic variability between generations to a minimum which is 
achieved by using, e.g., a certain number of breeding pairs (Chia et al., 2005). We onwards 
refer to inbred and outbred M. musculus models as lab mice, if nothing else is specified. 
 
Recombinant Inbred Strains, RIS, are a collection of mice established by inbreeding two 
existing inbred strains into a set of strains (often called set or panel). Each such strain is 
genetically homogenous, but “parallel” strains produced from the same two well-defined 
ancestral strains are genetically more different from each other than either of the two 
ancestors (Chia et al., 2005). One advantage of using a RIS set compared to pure inbred 
strains is that phenotypic differences (e.g. pathogen or drug susceptibility) can be fairly easily 
assigned to specific genotypes (Guénet et al., 2015), and obtaining high-quality quantitative 
data on transcripts and proteins is feasible (Chick et al., 2016). Other options for lab mice, 
such as genetic crosses, will be covered in section 6.2. 
 
We refer to wild rodents (including wild mice, e.g., species of Mus) as rodents which breed 
without direct intervention or manipulation by humans, in their natural habitats, e.g., 
farmland, forests or cities (Singleton and Krebs, 2007). Such populations may in some cases 
be under experimental study and manipulated, for example by regular trapping, diet 
manipulations and drug treatment, and will here still be considered as wild populations. 
 
3.2 Mouse housing influences experimental outcome 
Almost all animal research facilities can house rodents in specific pathogen-free, SPF, barrier 
facilities. This standard includes regular screening for a large set of common pathogens (in 
order to detect contamination), and commonly autoclaving cages, bedding, water, food and 
other housing related materials to assure hygienic and controlled housing, as well as 
controlled light/dark cycles (Hedrich and Nicklas, 2012). For details see respective lab 
manuals (Ayadi et al., 2011; Hedrich, 2012). Animal psychological status has been shown to 
influence variability in experimental studies, including examples of more reproducible results 
from “happier” mice, which display less anxiety or depression-associated behavior as a result 
of increased animal welfare (Bayne and Würbel, 2012). Although wild mice can run several 
hundred meters per night (Latham and Mason, 2004) including a means for physical activity 
(e.g. running wheels) is not standard in animal housing. Moreover, it is debated whether such 
so-called enrichment of housing is always required, beneficial, or adequate for the outcome of 
an experiment (Bayne and Würbel, 2012), given that after decades of breeding and selection 
lab mice in many respects show different behaviors to wild mice (Latham and Mason, 2004). 
 
Recent publications highlight the important role of microbiota in rodents (and humans). Even 
though SPF animals are the most commonly used rodents in experiments (Fiebiger et al., 
2016), gut microbiota are not homogenous (e.g. in composition or bacterial numbers) in such 
research settings and the extent of this variation has only recently emerged. Microbiota differ 
between vendors and mouse strains (Hufeldt et al., 2010; Ericsson et al., 2015; Hilbert et al., 
2017), different shipments from the same vendor (Hoy et al., 2015), between research animal 
facilities (Rausch et al., 2016) and even between rooms in the same breeding facility (Rogers 
et al., 2014). Determining factors for gut microbiota differences under SPF housing conditions 
without experimental perturbations have been analyzed, and apart from vendor, the fodder 
and treatment thereof is important (Rausch et al., 2016). Therefore, housing conditions 
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strongly influence mouse microbiota. Data also suggest a general difference between inbred 
lab mice and wild mice in that the proportion of Firmicutes versus Bacteroides vary, with 
wild rodents being dominated by Firmicutes and vice versa (Weldon et al., 2015). 
 
4. Misleading results due to inappropriate analysis or an inappropriate model  
“If you have cancer and you are a mouse, we can take good care of you“ (Kolata, 1998). This 
famous sentence from Judah Folkman (the “father” of tumor angiogenesis) makes this point: 
any model - animal or even mathematical - only returns the output it is capable of producing. 
A translational mouse model that lacks human feature X will never give a response in X, no 
matter how important that particular feature is in the context of a human disease. While the 
mouse model has been very successful for understanding the general principles of the 
mammalian immune system and infectious disease (e.g. Buer and Balling, 2003), it is 
important to be aware of, and acknowledge, the intrinsic benefits and limitations in any model 
chosen for a specific experiment. However, before we focus on biological confounders we 
want to consider that failures in the transition from preclinical studies to humans may also be 
due to poorly designed or performed studies (see Couzin-Frankel, 2013; Justice and Dhillon, 
2016). To illustrate that problems of very different character can challenge the suitability of 
translational rodent models, we will first discuss two past examples from different disciplines 
(sepsis and immunology) that caused vibrant discussions in the scientific community and 
were subsequently analyzed in great detail. They can thus provide valuable insights of general 
importance for scientists with different research interests. In section 5 we will then turn to 
confounders in translational rodent models of infections with protozoan parasites.  
 
4.1 Analysis, re-analysis and meta-analysis - three studies and three conclusions 
Due to its importance for human health, research on sepsis in mouse models is heavily 
funded, but its translational success has so far been disappointing (van der Worp et al., 2010). 
Few papers in biomedical research have therefore raised such an excitement and storm of 
replies and counter-replies as the Seok et al. 2013 study on sepsis. They analyzed 
transcriptomic data from various mouse models of human inflammatory diseases, and human 
samples in particular from septic shock, and concluded that “genomic responses in mouse 
models poorly mimic human inflammatory diseases“ (Seok et al., 2013). However, re-analysis 
of the very same data subsequently concluded the opposite, and these authors simply replaced 
“poorly” with “greatly” in the article’s title of their reply (Takao and Miyakawa, 2015). This 
discussion is still ongoing, with a recent paper (Weidner et al., 2016) pointing out that the data 
from Seok et al. per se are good enough to compare the transcriptional responses of certain 
(but not all) mouse models to humans, but that the analytical tools used in the two first papers 
were inappropriate. The authors’ conclusions were that gene set enrichment analysis (GSEA) 
is more appropriate than gene-to-gene comparisons, which require setting an arbitrary 
threshold for the determination of differentially expressed genes (as opposed to identification 
by statistical means). Those tools were used differently by various authors for re-analyses of 
the original data sets, thus leading to opposite conclusions (Seok et al., 2013; Shay et al., 
2013; Takao and Miyakawa, 2015; Warren  et al., 2015). A further level of complexity that 
makes conclusions derived from transcriptomic comparisons challenging is that for many 
genes there is no correlation between mRNA levels and protein quantities (see section 7.2). 
Although transcriptome analysis is a fairly easily accessible and promising technique, these 
examples illustrate that such relatively young tools require close evaluation of the entire 
work-flow. Understanding and considering the physics or chemistry behind the method and to 
critically assess appropriate analysis methods is a community task when new scientific 
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methods are being established. 
 
4.2 The CD28 superagonist antibody “disaster”  
It is well known that substantial differences between the mouse and human immune systems 
exist (Mestas and Hughes, 2004; Zschaler et al., 2014; Sellers, 2017) and that they need to be 
considered when using mice as preclinical models of human disease (e.g. Beura et al., 2016). 
In 2006, a small human phase I clinical trial aimed at alleviating rheumatoid arthritis tested a 
humanized monoclonal antibody, TGN1412, directed against the human T cell receptor 
CD28. However, instead of improving the autoimmune condition, it resulted in devastating 
consequences (reviewed by Hunig, 2016). It was anticipated from laboratory mouse studies 
that injection of the antibody would result in the preferential production of regulatory T cells, 
followed by a downregulation of active T cells. However, all six volunteers had to be 
hospitalized and at least four of them suffered multiple organ dysfunctions. TGN1412 had 
caused an immediate “cytokine storm” in these patients due to substantial TNF-α release, 
followed by dramatically increased plasma concentrations of several cytokines. This 
“cytokine release syndrome” (CRS) was caused by a strong activation of CD4+ effector 
memory T cells, which eventually caused severe tissue damage. But why had preclinical 
studies in primate models, namely cynomolgus and rhesus monkeys, not indicated any signs 
of problems? What was unknown in 2006 was that those primates’ CD4+ effector memory T-
cells do not express CD28 whereas humans do (Eastwood et al., 2010). In this particular case, 
the monkeys were a poor model for humans, despite their phylogenetically close relationship.  
 
And why had the human response not been seen in the numerous rodent experiments 
performed prior to the trial? Interestingly, later experiments have demonstrated that at least 
two drastically modified lab mouse models can indeed be good models for the TGN1412 
experiments. The first example is linked to the fact that, as is the case for most immunological 
experiments, mice in the initial studies had been raised and kept under SPF conditions. 
Thereby, they had no exposure to microbial antigens that would elicit CD4+ memory T cells. 
Thus, CRS was not initiated upon TGN1412 treatment as it was in humans. Consequently, 
when TGN1412 was later given to non-laboratory “dirty” mammals (including rodents, see 
section 6.3) exposed to prior environmental microbial stimuli, they experienced similar 
syndromes as the human volunteers (Eastwood et al., 2010). The second alternative model 
consists of humanized mice (see section 6.2). A recent study made use of mice which had 
been reconstituted with human peripheral blood mononuclear cells. Injecting TGN1412 into 
those animals recapitulated a number of the disastrous immunological outcomes also seen in 
the initial human trial (Weissmuller et al., 2016). Importantly, the transplanted human cells 
also included a small amount of effector memory cells. Therefore, both the use of “dirty” and 
humanized mice better mimicked human biology than the rodent models which were used in 
the pre-clinical studies (although both these models have gained interest more recently and 
were, if at all, very new ideas at that time).  
 
5 Non-genetic confounders in rodent infections with protozoan parasites 
Lab rodent models have been essential for understanding molecular, cellular, and 
immunological responses; however, most of the variability inherent in natural populations is 
not captured by them (Pedersen and Babayan, 2011; Beura et al., 2016). Even so, sources of 
variation which influence experimental outcomes in lab experiments have also been identified 
in these very models. Reports based on lab experiments have often not accounted for such 
variability and instead ascribed differences between experimental groups to the aspect under 
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study.  
 
5.1 Microbiota as a general confounder for rodent experiments 
Recently, the role of microbiota as a confounder for experimental outcomes in various 
scientific fields has gained increasing interest (Servick, 2016), largely due to the development 
of next-generation sequencing and related methods. Common approaches to study microbiota 
include sequencing fecal content from lab mice and germ-free mice (discussed in detail in 
Fiebiger et al., 2016), fecal transplants, antibiotics treatment, probiotics, addition of a specific 
bacterium, and infectious agents. For biomedical research it is noteworthy that microbiota 
influences host susceptibility to drugs. One example are proteins encoded by drug processing 
genes, DPGs, which are responsible for uptake, distribution, metabolism, and excretion of 
xenobiotics such as drugs (Aplenc and Lange, 2004; Klaassen et al., 2011). DPGs in mouse 
liver display different expression patterns depending on the microbiota status of the animal 
(Fiebiger et al., 2016). Some authors have linked microbiota differences to subsequent 
variation in brain activity and changes in social behavior, a concept referred to as the gut-
brain axis (e.g. Foster and McVey Neufeld, 2013; Mayer et al., 2015; Gacias et al., 2016) 
which is proposed to depend on several factors, including the immune system. Variation in 
microbiota is known to influence both local and systemic immune function by altering the 
balance of Th1/Th2 cell composition, influencing re-localization of neutrophils, or affecting 
macrophage polarization (Denny et al., 2016; Lopes et al., 2016). Taken together, it is 
therefore not surprising that differences in microbiota can have a substantial impact on 
protozoan parasite infections in the gut and elsewhere. It is also easy to imagine a situation in 
which genetically modified mice obtained from one breeder or lab and control mice from 
other sources leads to unintended differences in microbiota composition with resulting 
influence on the outcome of infection experiments.  
 
5.2 Protozoan infection experiments are influenced by microbiota 
One early study pointing to the importance of microbiota for the establishment of a protozoan 
infection used germ-free mice which were infected with the intestinal parasite G. duodenalis 
(Torres et al., 1992). The authors demonstrated that the microbiota influences the 
establishment and nature of intestinal infection with regards to severity and parasite 
reproductive success. A later study showed that female mice with the same genetic 
background were either susceptible or resistant to G. duodenalis infection (Singer and Nash, 
2000). Differences were due to the origin (vendor) of the animals, and the same was true for 
immunodeficient mice. Co-housing led to resistance in all animals, whereas treatment with 
antibiotics made all animals equally susceptible to intestinal infection. It was therefore 
concluded that the microbiota determined the outcome of infection. These studies have 
recently been complemented with more in-depth investigations of the microbial community, 
showing changes in the amount of microbiota and its composition upon G. duodenalis 
infection in mice (Barash et al., 2016). Hence, not only do microbiota influence infection 
outcome but the parasite in turn alters the gut microbiota. These studies emphasize the 
complexity of gastrointestinal parasite infections. Further analysis of microbiota-parasite-host 
cohabitation will likely reveal interactions such as competition for nutrients or synergies in 
metabolism.  
 
The complexity of microbiome influences is not limited to gut microbiota. Skin microbiota 
has also been shown to influence the outcome of cutaneous leishmaniasis in mice. Its 
causative agent, L. major, differently induced skin lesions, edema, and necrosis in germ-free 
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mice compared to SPF mice upon intradermal infection (Naik et al., 2012). Germ-free mice 
displayed less disease severity, but also reduced levels of IFN-γ and IL-17A from ɑβ T cells 
in the infected skin area compared to SPF reared animals. By orally administering antibiotics, 
the gut microbiota, but not skin microbiota, changed without influencing cytokine production. 
However, introduction of a skin commensal bacterium, Staphylococcus epidermis, did rescue 
IL-17A production in the skin. The authors concluded that local cytokine production was 
specifically linked to skin microbiota. In a different study, L. major infection altered the gut 
microbiota of infected animals (but differently depending on mouse strain). Infection changed 
how gut microbiota correlated with systemic functions such as urine metabolites, plasma 
metabolites, and the immune system (Lamour et al., 2015). Such findings also highlight that 
simple correlations between microbiota and protozoan parasites may not be adequate to 
elucidate the dynamic role of microbiota during infection. 
 
Interestingly, the microbiota does not only affect the site of infection but can also influence 
how host and parasite interact at other sites. Recent work provided evidence that the severity 
of malaria infection with rodent Plasmodium spp. can also depend on vendor. Differences in 
disease severity correlate with differences in microbiota composition (Villarino et al., 2016) 
or bacterial transcription profiles (Stough et al., 2016), demonstrating systemic effects by the 
microbiota. A study from 2014 also reported a mechanism for such correlations, describing 
production of anti-Plasmodium spp. antibodies in response to gut colonization, specifically by 
E. coli O86:B7 but not by the reference E. coli K12 (Yilmaz et al., 2014). These studies 
demonstrate that infections in specific compartments which are not colonized by commensal 
bacteria are nevertheless influenced and such effects must be considered in planning 
experiments and interpreting results. 
 
Excursion 1 - A reductionist in vitro approach using organoids  
Protozoa-host interaction studies have largely been restricted to more or less suitable rodent 
models, cell lines (often cancer-derived), and short-lived primary tissue cultures from biopsy 
or surgery. Recent advances in stem cell research have paved the way for the development of 
self-renewing and complex tissue-like culture systems, so-called organoids, which mimic 
organs in their main functions and structural features (Willyard, 2015). Major advantages 
include that host-parasite interactions can be investigated in a primary, long-lived, organ-like 
tissue from the organism of choice, including humans, in real time (Klotz et al., 2012). 
Organoids have been developed from the gastro-intestinal tract (GIT), including stomach, gut 
and liver, and also from kidney and brain (Clevers, 2016). Importantly, organoids lack tissue-
specific immune cells and in the GIT the microbiota, and therefore complexity is low 
compared to in vivo settings. However, this feature allows the researcher to construct an 
experimental setup with exactly the desired level of complexity, adding for instance the 
Mouse Intestinal Bacterial Collection (Lagkouvardos et al., 2016), human microbiota from 
biopsies, and/or a set of cytokines or immune cells of interest. For elucidating the role of 
individual actors during a parasitic infection, organoids are promising alternatives to animal 
models, cell culture systems, and the use of human biopsy material. 
 
5.3 Sex and age 
Two long-known factors that influence infection success by parasites are sex and age. The 
most obvious differences between the sexes are hormones (Roberts et al., 2001; Klein, 2004; 
Bernin and Lotter, 2014) but X chromosome-linked mutations (van Lunzen and Altfeld, 2014; 
Garenne, 2015) and sex-specific behavior can also affect the outcome of infectious diseases. 
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A prominent example in protozoan infections is glucose-6-phosphate dehydrogenase (G6PD) 
deficiency, which protects humans of both sexes to different extents from clinical outcomes of 
infections with P. falciparum (Shah et al., 2016). A previously developed humanized mouse 
model of G6PD deficiency (Rochford et al., 2013) has recently been used in screening efforts 
to identify malaria transmission-blocking drugs (Wickham et al., 2016). A second example 
involves X-linked immunodeficiency in the B-cell responses due to mutations in the Bruton's 
tyrosine kinase. The mutation causes a sex-specific effect which leads to X-linked 
agammaglobulinaemia (XLA). Human patients and mice bearing a similar mutation (CBA/N) 
are more prone to develop chronic giardiasis (Skea and Underdown, 1991; Van der Hilst et 
al., 2002). 
 
In rodent models of, e.g., Plasmodium spp., Cryptosporidium spp., and Leishmania spp., age 
significantly influences susceptibility (Adam et al., 2003), parasite reproductive success (Rhee 
et al., 1999), and severity of disease (Muller et al., 2008). In the case of Cryptosporidium 
(Rhee et al., 1999), hamsters displayed age-dependent differences (within the first two months 
of life) in infection persistence measured by time for shedding oocysts, whereas mice did not. 
The results demonstrate that rodents can be used to study cryptosporidosis, but simultaneously 
suggest that generalizations of these results to other species are difficult, and translational 
success is not obvious. For leishmaniasis, recent work showed mouse age-specific differences 
in the induction of adaptive immunity. Animals were exposed to a vaccine candidate based on 
genetically modified L. donovani and aged mice (~16 months) had a less pronounced adaptive 
immune response compared to young mice (~2 months) upon L. major challenge after 
vaccination (Bhattacharya et al., 2016). In Babesia microti infection of lab mice between the 
ages of two and 18 months (Vannier et al., 2004), one of three strains (DBA/2 mice) 
mimicked patterns seen in humans in which susceptibility and an inability to clear infection 
increased with age. The other two strains displayed smaller differences in susceptibility and 
no change in infection clearance, illustrating possibilities to use rodents as models for human 
babesiosis, but alerting to possible issues with interpretation and translation of results.    
 
Given these examples it seems obvious to consider age and sex aspects when planning rodent 
experiments. However, it is not unusual to use only male or only female mice (Flórez-Vargas 
et al., 2016) based on convenience, local availability, costs, legal issues (more animals 
required when both sexes are examined; Clayton and Collins, 2014) or research area. In 
particular in infectious disease research there is a strong bias towards using female mice 
(Flórez-Vargas et al., 2016). One reason for this is presumably that they are less aggressive 
and thus cheaper since they can be housed in (experimental) groups in a single cage whereas 
this is challenging for male mice. Likewise, younger mice are cheaper to obtain since housing 
cost are lower. Thus, convenience rather than scientific reasoning might influence the choice 
of sex or age in many studies. 
 
 
6 Models for all purposes - from fixed alleles to complex ecology 
Even before the first draft of the mouse genome was published in 2002 (Waterston et al., 
2002), scientists were aware of the relative genetic homogeneity of the lab mouse compared 
to wild mouse populations (Guenet and Bonhomme, 2003). Inbreeding over almost a century 
fixed alleles in currently available lab mice, which now represent just a fraction of the genetic 
variability found in nature. Although a desirable feature for some questions, this variability 
can be of great importance in studies of host-parasite interactions. Genetic variability might 
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be the reason for different host susceptibility together with, e.g., the confounders discussed 
above (see section 5). In many cases allelic variations of a gene involved in immune 
responses were identified as the cause of infection outcome.  
 
6.1 When immune responses depend on genetics - selected examples 
Allelic variation at Lsh and H2 loci is involved in the opposite outcome of the acquired 
immune response in L. donovani infection between e.g., CBA and BALB/c mice (Loeuillet et 
al., 2016). Another emerging example is the role that the inflammasome has in sensing 
protozoan infections (reviewed in Zamboni and Lima-Junior, 2015). During T. gondii 
infection in rodents, sequence differences in the pathogen sensor Nlrp1 accounts for species-
specific inflammasome induction - and thus outcome - in lab mice (Ewald et al., 2014) and rat 
strains (Cirelli et al., 2014). Phenotypic differences between model animals can also be due to 
polymorphisms in the inflammasome pathway effectors, e.g., IL-18 and IL-1β. A study on a 
wild, natural population of field voles (Microtus agrestis) found associations with 
polymorphisms of IL-1β, IL-2 and IL-12β and differential susceptibility to pathogen infection 
(Turner et al., 2011), with the impact on susceptibility being comparable to parameters like 
sex and body weight. The parasites considered in the study were mostly nematodes, cestodes 
and B. microti, making the influence of these cytokines’ polymorphisms in other protozoan 
parasite infections a likely scenario.  
 
Recently, polymorphisms in immunity-related GTPases (IRGs) affecting the rodent immune 
responses to T. gondii were described in a study comparing the DNA sequences of several 
inbred and wild-derived mice (Lilue et al., 2013). Remarkably, the authors showed that while 
the sequences of all the examined lab mice were highly conserved, genes in the wild-derived 
mice were extremely diverse, comparable to the diversity of MHC genes. One of those genes, 
the highly polymorphic Irgb2-b1 from a wild-derived M. musculus, when expressed in 
C57BL/6 fibroblasts, was sufficient to confer resistance (i.e. prevent cell lysis) to so-called 
virulent strains of T. gondii. While 1-10 parasites of these strains can kill a lab mouse, IRG-
polymorphic wild-derived mice are resistant to infection by much higher numbers of the same 
T. gondii strain. Apart from highlighting extensive sequence variability of wild-derived but 
not classical inbred laboratory strains in these gene loci, this work emphasizes that the 
definition of virulence is heavily dependent on the animal of choice and that its definition 
should always be accompanied by stating the experimental conditions. In the following 
section we move from traditional, genetically homogenous and inbred mice to mice 
manipulated to resemble aspects of the human immune system, and then to genetic crosses 
between inbred and wild-derived mice. Lastly, we will turn our attention to “dirty mice” and 
wild rodents in natural settings.  
 
6.2 Humanized mice: rodents which mimic the human immune system 
Designing an immune system with human features within the mouse - generating humanized 
mice - has recently emerged as an approach to expand the areas where lab mice can be used to 
model disease. Generation of humanized mice is based on immunodeficient animals (e.g. 
SCID, Rag2-/-) whose innate and adaptive immune systems are severely compromised and the 
animals are instead characterized by increased survival of transplanted human hematopoietic 
cells (Kaushansky et al., 2014; Good et al., 2015), which produce a large number of different 
human immune cells in the mouse. Depending on further needs, these mice can be populated 
with, for example human red blood cells and/or CD34+ hematopoietic stem cells that further 
give rise to T cells and antigen presenting cells (APC). Recent advances in the development 
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of humanized mice offer the possibility to study human infectious diseases which could 
previously not be investigated in mice, in the mouse model (Brehm et al., 2013). Even though 
the use of rodent infecting Plasmodium spp. such as P. berghei has greatly contributed to 
understanding the parasite’s biology and general principles of protective immune mechanisms 
in mammals (Craig et al., 2012), it is promising that human-infecting P. falciparum now can 
be researched in lab mice (Kaushansky et al., 2014). The basic strategy for generating 
humanized mice, and adaptations of it lead to the generation of mice in which the blood stages 
of human malaria parasite life cycles could be established (Kaushansky et al., 2014; Good et 
al., 2015).  
 
More advanced models with engrafted human hepatocytes (FRG-NOD huHep) have been 
further used to establish the complete development of the pre-erythrocytic liver stage of P. 
falciparum after mosquito bite, including formation of exo-erythrocytic merozoites, 
subsequently infectious to human red blood cells in the same mouse (Vaughan et al., 2012). 
Although the development of the mature sexual stages (gametocytes) that are necessary to 
complete the parasite life cycle is still inefficient, it seems possible that complete P. 
falciparum (and other human Plasmodium spp.) life cycles could be routinely maintained 
using humanized mice. Recently, such mice were also used to conduct a genetic cross 
between two P. falciparum strains in those animals, something that so far was only possible in 
nonhuman primates, including chimpanzees (Vaughan et al., 2015).  
 
These examples and others from several other infectious agents (Ernst, 2016), suggest that 
humanized mice will continue to contribute to a new repertoire of mouse translational models. 
Understanding host specificity factors for a given human pathogen is crucial for the design of 
susceptible humanized mice, and methods to identify such factors are described in detail by 
Douam et al. (2015). However promising, the establishment of these mice is relatively new 
and already several limitations are known (described in more detail in (Ernst, 2016), which 
limit the extent to which the models actually mimic the human immune system. For instance, 
several mouse cytokines differ largely in their sequences between mouse and human, and IL-
13 has no effect on human cells. This might explain the low proportions of certain human 
immune cell types in humanized mice. In addition, signaling and adhesion molecules are 
different between humans and mice and, importantly, the expression of murine and not human 
major histocompatibility complexes impairs the function of T cells. Attempts have been made 
to account for some of these limitations (Ernst, 2016) but so far humanized mice are probably 
best considered as a promising, but yet developing, tool in translational research.  
 
Even so, host-specificity has limited the choice of model systems for studying protozoan 
parasites. The Plasmodium spp. examples and initial attempts with L. major infection in 
humanized mice (Wege et al., 2012) hold promise for future possibilities to investigate also 
other human-specific protozoan parasite species in lab mice. 
 
6.2 Mixing the known – Recombinant Inbred Strains and the Collaborative Cross 
In order to document an influence of genetic heterogeneity on experimental results, models 
beyond inbred animals are required (Phifer-Rixey and Nachman, 2015; Chow, 2016). This is 
also true in translational research, where humans represent a genetically diverse population. 
When the aim is to find differences across the genome, as in genome-wide association studies 
(GWAS) where a given phenotype is thought to be linked to genetics, outbred stocks of mice 
or rats are not a solution since they are “a genetically ill-defined set of laboratory mice that 
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are often used erroneously in toxicology, pharmacology and basic research” (Chia et al., 
2005). In addition, their usefulness is limited for practical reasons, e.g., individual phenotypic 
variability requires larger sample sizes than necessary with inbred strains, or the study will 
lack statistical power to correlate experimental differences with certain genotypes (see Chia et 
al., 2005; Festing, 2014). In order to address the problem of limited genetic diversity but 
avoid the ill-defined genetic composition of wild animals, numerous mouse collections 
besides the RIS (see section 3.1) have been established.  
 
The concept for producing RIS sets has been extended by the Complex Traits Consortium to 
produce more genetically variable sets. These are known as Collaborative Crosses (CC) and 
are based on a set of 8 defined and sequenced founder strains, including three wild-derived 
strains of Mus and five traditional inbred strains. Although the set of strains is genetically 
diverse, each CC strain is at least 90% homogenous and hence genetically well-defined (Chia 
et al., 2005). The CCs were designed specifically for complex trait analysis (Churchill et al., 
2004; Threadgill and Churchill, 2012) and the derived Diversity Outbred (DO) population 
(Churchill et al., 2012) has resulted in an even more genetically diverse mouse population 
(see Fig. 3). Other derivatives of CC’s concept exist, like the Heterogeneous Stock mice 
(Valdar et al., 2006) or the Hybrid Mouse Diversity Panel (Bennett et al., 2010). Besides 
GWAS studies, which map determinants for non-infectious diseases, CC animals have 
recently been used to map susceptibility or pathogenesis determinants in bacterial and viral 
infection models (Durrant et al., 2011; Ferris et al., 2013; Rasmussen et al., 2014; Vered et al., 
2014; Gralinski et al., 2015; Lore et al., 2015; Smith et al., 2016). However, no data for 
parasite infections have been reported so far, and their large potential for exploring how host 
genotype influences infections needs to be explored in the future. Nevertheless, CC and DO 
mice also have limitations (Phifer-Rixey and Nachman, 2015). They are all derived from 
subspecies, which limits the genetic variation and may cause partial hybrid sterility in crosses. 
This, in turn, might have resulted in the elimination of genetic variation at these genomic loci. 
However, it is expected that further crosses will improve these models on the genetic level.  
 
Yet, these mice will never approach the genetic diversity found in the human population or 
wild animal populations. In addition, individuals in natural populations encounter seasonal 
and spatial variability in the environment, as well as differences in climate and food 
availability. Wild animals are also exposed to and infected with a vast array of parasites and 
other pathogens, harbor different microbiota, and individuals vary in their demography, 
behavior and genetic composition. While it is possible to add key elements of natural 
variation into the above described rodent model systems, there is an increasing interest in 
moving beyond the controlled laboratory setting to a more realistic scenario. 
 
Excursion 2: Metabolic disease in lab mice and humans - is ecological complexity better 
than SPF facilities? 
Around 25% of the world population has a metabolic syndrome, defined by the International 
Diabetes Federation as either diabetes / prediabetes, abdominal obesity, high cholesterol or 
high blood pressure. Animal studies provide important information on these conditions 
(Bäckhed et al., 2004; Turnbaugh et al., 2006). The role of microbiota has gained interest also 
in this field because of potential new treatments which can manipulate the microbiome 
community and function (Borody and Khoruts, 2012). Of interest here are the large numbers 
of studies conducted in rodents which demonstrate, for instance, alterations in body weight 
and insulin sensitivity which correlate with changes in microbiota upon antibiotics treatment 
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in these model rodents (Bäckhed et al., 2004; Turnbaugh et al., 2006). Although similar data 
also exists from human studies and therefore support that translation of results from rodent 
models to humans in this case is possible, a recent contribution to this topic questions the 
rodent model to mimic metabolic disease and microbiota correlations in humans. In a study 
performed on 57 overweight and obese adult men, the systemic effects of two antibiotic 
treatments compared to placebo were investigated (Reijnders et al., 2016). Changes in 
microbiota composition (detected by 16S rRNA microarray analysis) were observed for 
specific antibiotics against gram-positive bacteria, but no differences were seen with the 
broad-spectrum antibiotic. On most other readouts, the authors did not see significant 
responses to antibiotics treatment. Hence, changes in microbiota composition did not correlate 
with changes in systemic functions in humans (e.g. insulin sensitivity, energy metabolism and 
gut permeability; Reijnders et al., 2016), which is in contrast with rodent data (Bäckhed et al., 
2004; Turnbaugh et al., 2006). Reijnders et al. (2016) discuss hypotheses for these 
discrepancies, mentioning treatment duration and the method of antibiotic intake (capsules or 
in water). In addition, a possibly important difference between the described rodent studies 
and the human study is the fact that humans are a “wild” population. The genetic 
heterogeneity and environmental influences in the human population of 57 men are indeed 
different from the SPF bred rodents. The effects of both previous and current microbe 
colonization and/or infections do influence immune responses in an individual and constitute 
an important difference between wild and controlled laboratory populations (reviewed in Tao 
and Reese, 2017). Possibly, the use of a “dirty” or wild rodent population would be a more 
suitable choice when the aim is to investigate correlations in a highly complex biological 
system. 
 
6.3 Getting the rodent model “dirty” 
In the continuum of approaches that can be employed to better understand protozoan parasite 
infection and immunity, “dirty” animals taken from the wild or laboratory animals exposed to 
wild cage-mates have emerged as a promising model (Maizels and Nussey, 2013). Arguing 
for such translational models, recent results demonstrate that inbred mice reared in SPF 
conditions have the immunological phenotype of neonatal humans, lacking effector-
differentiated and mucosally distributed memory T cells (Beura et al., 2016). In contrast, 
“dirty” M. musculus brought in from either a pet shop or from feral barn populations had 
immune responses more similar to adult humans, with high levels of memory CD8+ cells, 
likely due to diverse microbial exposure and infection. These changes in both the innate and 
adaptive immune cellular responses and immune gene expression could also be recapitulated 
by co-housing previously SPF inbred mice with pet shop mice. While about 20% of the SPF 
mice died due to microbial infection, the immune response of those that survived also 
resembled adult humans within 4-8 weeks, with effector-differentiated and mucosal memory 
T cells. In addition, within that short time frame, co-housed mice responded similarly to the 
wild-caught pet shop mice in terms of infection, such that they were significantly more 
resistant, amongst other pathogens, to challenge with the cerebral malaria model P. berghei 
(Beura et al., 2016). Another research group has aimed to make their inbred laboratory mouse 
strains “dirty” by giving them sequential infection with mouse herpes virus, influenza and an 
intestinal helminth in order to test how this more natural pattern of exposure to pathogens may 
affect immune variation and expression after vaccination. They found that co-infected mice 
had different immune gene signatures, cytokine expression and antibody levels in the blood 
both before and after yellow fever virus vaccination compared with their SPF lab mice 
controls. These expression patterns resembled those of pet store-raised mice (Reese et al., 
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2016). While getting the traditional sterile laboratory mouse models dirty may pose logistical 
challenges, such results should encourage researchers to revisit abandoned vaccine candidates 
as well as to establish different routines for testing new ones.  
 
6.4 Benefits of using wild mice 
Studies on dirty mice with the benefits described above still lack other aspects of natural 
variation that are important (Pedersen and Babayan, 2011). Thus, there is a need for wild 
model organisms that permit robust studies of the individual and environmental variation 
inherent in natural populations (including humans). Populations of wild mice vary in many of 
the same ways as humans (e.g. age, sex, condition, resources, parasite exposure, infection/co-
infection, genetics, etc.), yet can provide a tractable, experimental system to test the 
importance of natural variability on infection, immunity and disease control. There are several 
key epidemiological features in wild mouse populations that closely resemble human 
infection dynamics, such as having great variation in infection probability, burdens and 
disease severity across individuals. Moreover, wild mice are commonly found chronically 
infected with parasites, suggesting either a high frequency of re-infection, long-lasting 
infections, or both (Pedersen and Babayan, 2011; Knowles et al., 2013).  
 
One approach to start a research program on wild rodents is to study the traditional laboratory 
mouse species (M. musculus) in the wild (Potter et al., 1986; Viney et al., 2015). Abolins et al.  
(2011) found that the immune function of wild-caught M. musculus was significantly greater 
than lab-reared C57BL/6 mice, such that after immunization with a novel antigen wild-caught 
mice had higher concentrations of total IgG and IgE, produced higher and more avid 
concentrations of antigen-specific IgG, and had greater activation of T helper cells, 
macrophages and dendritic cells than lab-reared mice. While wild M. musculus offer a great 
parallel to lab-reared mice and can serve as comparisons for protozoan infection in the 
laboratory, many studies do not exhaustively sample for ectoparasites and protozoans and 
their true infection status is not well described. Commonly, wild M. musculus are reported to 
be infected with mainly ectoparasites and a few nematodes (mostly Syphacia spp. pinworms; 
e.g. Weldon et al., 2015); however there are records of natural infections with Giardia muris, 
Spironucleus muris, and Encephalitozoon cuniculi (Baker, 1998), Eimeria spp. (Ball and 
Lewis, 1984), Cryptosporidium spp. (Backhans et al., 2013) and T. gondii (Kijlstra et al., 
2008). 
 
6.5 Rodents beyond wild mice are natural hosts of a wide variety of protozoa 
Beyond M. musculus, there are several well-studied wild rodents that are both commonly 
infected with protozoan parasites and also offer tractable wild model systems for both 
longitudinal and experimental studies of infection and immunity. In North America, much 
work has focused on white-footed mice and deer mice (Peromyscus leucopus and P. 
maniculatus) both because they are very abundant and widespread, but also because they are 
competent reservoirs of important emerging zoonotic pathogens (e.g. Hantavirus and Borrelia 
spp.; Bedford and Hoekstra, 2015). In Europe, wood mice (Apodemus sylvaticus; e.g. 
Knowles et al., 2013), yellow-necked mice (A. flavicollis; e.g. Ferrari et al., 2004), bank voles 
(Myodes glareolus; e.g. Withenshaw et al., 2016), and field voles (M. agrestis; Smith et al., 
2005; Turner et al., 2014) have been commonly studied as models for wild host-pathogen 
interactions and are all regularly infected with protozoan parasites. For example, wild 
populations of A. sylvaticus in the United Kingdom have been found to be infected with C. 
parvum, C. muris (Chalmers et al., 1997); > five species of Eimeria (Ball and Lewis, 1984; 
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Higgs and Nowell, 2000); Babesia sp. and Hepatozoon sp. (Turner, 1986); two species of 
Trypanosoma (Noyes et al., 2002), Frenkelia microti (Svobodova et al., 2004) and T. gondii 
(Jackson and Siim, 1986). It is very likely that this list is a far from exhaustive.  
  
The benefits of using wild rodent-parasite models to better understand protozoan infection 
dynamics include the ability to: (i) conduct longitudinal field experiments which follow 
marked individuals throughout their lives while measuring infection status, physiological and 
demographic metrics (Knowles et al., 2013; Pedersen and Antonovics, 2013; Turner et al., 
2014), and crucially (ii) test the efficacy of disease control interventions at the individual and 
population level in an ecologically relevant environment (Knowles et al., 2013; Pedersen and 
Antonovics, 2013). For example, in a population of wild field voles (M. agrestis) the 
researchers repeatedly treated one population with a standard insecticide to reduce the 
prevalence of fleas, and in turn, found that this reduced the prevalence of vector-transmitted 
Trypanosoma spp. by ~33% (Smith et al., 2005). In addition, in experimental field studies of 
both P. maniculatus and P. leucopus in the US, and A. sylvaticus in the UK, anthelmintic 
treatment was used to reduce nematode burdens within specific, marked animals. The 
treatment was found to unexpectedly increase the prevalence and/or intensity of co-infecting 
Eimeria spp., suggesting strong antagonistic within-host interactions between a worm and a 
protozoon (Knowles et al., 2013; Pedersen and Antonovics, 2013).  
 
Research on wild rodents benefit from the extensive immunological toolbox developed in lab 
mice (Pedersen and Babayan, 2011). In wild populations of A. sylvaticus, innate immune 
responsiveness, as measured by splenocyte tumour necrosis factor responses to toll-like 
receptor (TLR) agonists, was found to correlate positively with Eimeria spp. faecal oocysts 
counts, most strongly with receptors TLR7 and TLR9 (Jackson et al., 2009). More recently, 
the availability of genomes for wild rodents has enabled the ability to measure immunological 
expression in wild rodent populations. A recent investigation of wild field voles measured 
expression of a wide range of innate and adaptive responses by cultured and stimulated 
splenocytes. Importantly, repeated measures from peripheral blood samples of IFN-y, Gata3 
and IL-10 expression enabled the authors to test for correlations with specific parasite 
infections (Jackson et al., 2014). Taken together, wild rodents reach large sample sizes, can be 
repeatedly recaptured using live traps, marked and followed before and after interventions, 
and are commonly infected with protozoan parasites. Studying the dynamics of protozoan 
infections in wild rodents is a valuable resource for expanding our knowledge in infection 
biology and might thus be a useful addition for translational research on human protozoan 
infections.  
 
6.6 A case for going wild: do T. gondii-induced behavioral changes exist in natural 
habitats? 
How relevant are findings which suggest parasite influences on lab mouse behavior when 
performed in lab environments? The so-called “manipulation hypothesis” of a T. gondii 
infection in rodents suggests that infection leads to subsequent changes in the animal’s 
behavior, with one consequence being that they lose their fear for feline odor (e.g. fur or 
urine). Cats and other felids are the only definite hosts where sexual reproduction of T. gondii 
can take place. Therefore, at first sight it makes sense that such “manipulated” infected 
rodents would experience more fatal encounters with a cat than non-infected ones, thereby 
increase the chance for T. gondii to sexually reproduce with another strain from a second 
subsequent infected prey.  
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The advantage or necessity of this scenario for parasite sexual reproduction in the wild has 
been called into question (Worth et al., 2013), but here we focus on the fact that all reported 
experiments were done exclusively in lab animals (Worth et al., 2014). At first sight this 
might not seem problematic since M. musculus and T. gondii naturally occur together. 
However, it is well known, but not necessarily well appreciated, that behavioral studies of 
rodents can be influenced by the methods used, housing conditions, genetic background and 
whether they are lab or wild-derived animals (Wolff, 2003; Beckers et al., 2009; Fonio et al., 
2012; Chalfin et al., 2014; Newman et al., 2015). Even differences in the microbiota can have 
profound effects (Hsiao et al., 2013; see section 5.1). Moreover, lab mice have been selected 
for decades for docile behavior, while wild mice show anxious behavior under natural 
conditions (Latham and Mason, 2004; Yoshiki and Moriwaki, 2006; Fonio et al., 2012; 
Chalfin et al., 2014).  
 
How well does the manipulation hypothesis apply to the natural situation of predator (cat) and 
prey (T. gondii-infected mouse or rat)? Ecological observations might explain some of the 
observed discrepancies, i.e., no behavioral differences were found in one study but were 
indeed found in another (Worth et al., 2014). Several studies indicate that predation risk of 
wild or wild-derived small rodents depends more on habitat characteristics (e.g. ability to 
hide) than on whether the rodent senses a present predator by its odor or even by its physical 
presence (Orrock, 2004; Powell and Banks, 2004; Verdolin, 2006). Aversive responses to 
predator odor can also differ dramatically between individual lab rats (Hogg and File, 1994) 
and, importantly, between lab mice and wild mice (Coulston et al., 1993; Hebb et al., 2004). 
Thus, experiments with “fearless” lab mice in non-natural terrains may not accurately reflect 
the behavioral changes induced by a parasite like T. gondii under natural conditions. 
 
7 Experimental challenges and available resources for non-traditional rodent models 
Having provided a number of reasons for considering wild rodents as alternatives, we will 
briefly address the experimental challenges. Approaching studies on non-model rodents is 
demanding but the toolbox has improved significantly compared to a decade ago (Pedersen 
and Babayan, 2011; Zimmerman et al., 2014). Method development in the fields of genomics, 
transcriptomics and proteomics together with increasing affordability provide better 
prerequisites for research on non-model alternatives (Jackson, 2015). Next-generation 
sequencing has led to constantly expanding genomic data. This is demonstrated by the nearly 
4,000 eukaryotic genomes available on NCBI Genome (February, 2017) as compared to 
around 650 in 2013 (Ellegren, 2014). 
 
7.1 Database resources for wild rodent genomes 
Any resources available for lab mice are to varying extents useful starting-points for work on 
wild rodents. The Mouse Genomes Project is the biggest collection of genomic data on 
rodents (SI Table 1). Currently it consists of whole-genome assemblages and strain-specific 
gene annotations of 16 inbred and wild-derived mouse strains. A goal of this project is the 
classification of sequence variations between common laboratory strains compared to the 
reference strain C57BL/6J (Adams et al., 2015; Doran et al., 2016). All sequence reads, 
variants and assemblages can be useful references for highly recombinant outbred strains 
(Nicod et al., 2016) or wild rodent genomes. There are also increasing numbers of genomes 
and/or transcriptomes available for wild rodents (e.g. A. sylvaticus, M. glareolus and M. 
agrestis; see Fig. 4), with most of them being “work-in-progress” considering assemblage 
status and annotations (for details see SI Table 1 and links therein). The quality and coverage 
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of these genomes vary and there is for instance no clear definition of a required coverage for 
referring to DNA sequences as a “genome” (Ellegren, 2014). However, they do provide a 
good source for homology searches for a gene-of-interest, primer design for PCR applications 
etc. Naturally, purification of DNA, RNA or proteins and functional PCR protocols may 
require protocol optimization when applied to new species but otherwise follow established 
schemes. Some database resources and other initiatives to promote such development are 
discussed below and summarized in SI Table 1. 
 
While reference genomes are not a prerequisite for some studies they are, for instance, 
indispensable as a template in quantitative gene expression studies with high-throughput 
sequencing of RNA (RNA-seq; Vijay et al., 2013). However, bioinformatics pipelines are 
often developed for established model organisms and may require considerable adjustments 
for non-model organisms (Ekblom and Wolf, 2014). Although such limitations may hamper 
the speed of omics applications to non-model organisms, genomes of non-model rodents will 
serve as excellent resources for developing species-specific tools to measure for example 
expression of immunological responses to infection. Readers that are interested in considering 
genome sequencing for their own non-model organism are referred to a recent step-by-step 
introduction of the required workflows (Ekblom and Wolf, 2014) and to the Generic Model 
Organism Database (GMOD) initiative, which provides software tools and data models for 
subsequent representation of their annotated genomes and curated data of their model 
organism (O'Connor et al., 2008). 
 
7.2 Transcriptomes do not necessarily predict protein levels 
It should be emphasized that genomic and transcriptomic data, as valuable as they are, 
provide only indirect means with regards to proteomic output in response to infection. In 
general, the relationship between the concentration of a given transcript and its encoded 
protein(s) is difficult to predict just by RNA-seq or qPCR data (Liu et al., 2016). For example, 
Chick et al. used the currently most sensitive technology for abundance determination of both 
transcripts and proteins and applied them to CC and DO mice (see section 6.2 and Fig. 3; 
Chick et al., 2016). They showed that for many genes the levels of the corresponding protein 
varied substantially in genetically divergent mice. Sex also influenced protein amounts within 
a given species (Chick et al., 2016). These recent data emphasize the importance of 
quantitative proteomic measures in general to complement or validate transcriptomic data, but 
also highlight that genetic diversity within mice influences the results. 
 
7.3 Antibodies, cytokines and protein quantification 
Antibody-based assays are still the cornerstone for qualitative and quantitative determination 
of immunological parameters like chemokines or cytokines but also other proteins of interest. 
Numerous well-defined and evaluated reagents exist for lab mice and rats but their usefulness 
for wild rodents with respect to cross-reactivity is largely unexplored and presumably quite 
low in many cases. The same applies to immunological effector molecules like cytokines, for 
which IFN-γ is a good example. IFN-γ is known to be highly species-specific, which made the 
production of a recombinant protein active with M. glareolus or Microtus spp. cell lines a 
prerequisite (Torelli et al, in preparation). Starting from genomic sequences and going to the 
purification of active recombinant protein from E. coli required less than half a year and will 
now provide the scientific community with this important cytokine.  
 
Developing antibodies that (cross)react with wild rodents is certainly much more time and 
resource-consuming, but feasible. An alternative could be parallel (or selective) reaction 
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monitoring (PRM, SRM) which are mass spectrometry-based methods that quantify unique, 
specific peptide sequences of a given protein (Rauniyar, 2015; Bourmaud et al., 2016). The 
method was recently used to quantify several cytokines and chemokines from human cells 
(Muqaku et al., 2015). The appealing aspect of this admittedly demanding method lies in the 
fact that by carefully selecting peptide sequences conserved between rodent species, they 
could be used across those species at relatively low cost, once established (Hüttenhain et al., 
2009). Ideally, it could thus be regarded as a community effort. A database with 
corresponding peptides from human and mouse proteomes does exist (see SI Table 1) and 
constitutes a useful starting point (Peptide Atlas; Deutsch et al., 2008). 
 
Given the availability of published genomic and transcriptomic data of wild rodent species (SI 
Table 2) work similar to the studies mentioned will hopefully expand the current toolbox for 
non-model rodents in the near future. A dedicated web site with information on such shared 
resources, but also on cross-reacting reagents such as polyclonal or monoclonal antibodies or 
commercial cytokines and other proteins tested in non-model rodents, although not yet 
existing, would greatly boost the interest and ease of use of non-model organisms in future 
studies. 
 
8 Concluding remarks  
We are convinced that rodents will continue to be important translational models for research 
on protozoan parasites, given that appropriate considerations are made during experimental 
design. By providing some examples where translation from rodent disease models to human 
medicine has failed, and, more importantly, by pointing at identified reasons for inconclusive 
or misleading data, we wish to inspire readers to consider more than the most convenient 
model for future experiments. Making use of rich database-resources that are available for 
investigating, e.g., expected phenotypes of mice, will aid in this respect. We also hope that 
readers are encouraged to consider and control for various confounders such as microbiota 
influences and housing conditions in their experimental designs. While wild models pose 
some challenges, we have pointed out that these rodents possess distinct advantages with 
regards to genetic variability and environmental exposures that can reflect immunological 
responses to parasites in humans more adequately than current lab models. The increasing 
availability of genome and transcriptome datasets as well as improved methods for 
quantitative proteomics already show their impact on wild infection biology. 
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Table 1 Global “Disability-Adjusted Life-Years”, DALYs, for high impact infectious 
diseases, with several examples from protozoan parasites. Data shown for 2010 and 2015. For 
causative agents of protozoan diseases see Table 2. 
 DALYs (*1,000) 2010 1 DALYs (*1,000) 2015 2 
Lower respiratory infections 115,227 (95,983)3 142,384 
· Influenza 19,244 nr 4 
Diarrhoeal diseases 89,513 (78,904)5 84,928 
HIV/AIDS 81,547 62,759 
Tuberculosis 49,396 56,037 
Protozoan diseases, total 97,884 (15,199) 6 40,695 
· Malaria 82,685 38,520 
· Leishmaniasis 3,317 1,357 
· African trypanosomiasis 560 372 
· Chagas disease 546 253 
· Trichomoniasis 167 194 
· Cryptosporidiosis 8,372 nr 4 
· Amoebiasis 2,237 nr 4 
1 Murray et al., 2012 
2 Kassebaum et al., 2016 
3 number in brackets = without influenza 
4 nr = not reported 
5 number in brackets = without cryptosporidiosis & amoebiasis 
6 number in brackets = without malaria 
 
 
 
Table 2 The diseases caused, transmission routes, and suitability of rodents as models for 
human disease are listed for selected protozoan parasites. Reference is given to a single article 
describing the basic biology of the respective protozoan to serve as starting point for further 
reading. 
Parasite species Disease  
(organ(s) mainly 
affected) 
Transmission 
route 
Suitability 
of rodent 
model for 
human 
infectious 
species 
Reference 
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Plasmodium 
spp. 
Malaria  (blood 
and liver) 
Vector (yes) Cowman et 
al., 2016 
Toxoplasma 
gondii 
Acute and 
congenital 
toxoplasmosis 
(brain, heart, 
systemic) 
Food, water, 
congenital 
yes Schluter et al., 
2014 
Cryptosporidium 
spp. 
Cryptosporidiosis 
(intestine) 
Food, water (yes) Checkley et 
al., 2015 
Trichomonas 
vaginalis 
Trichomoniasis 
(urogenital tract) 
Sexual (yes) Kusdian and 
Gould, 2014 
Giardia 
duodenalis 
Giardiasis 
(intestine) 
Food, water (yes) Ankarklev et 
al., 2010 
Entamoeba spp. Amoebiasis 
(intestine, liver, 
other organs) 
Food, water (yes) Stanley, 2003 
Leishmania spp. Cutaneous and 
visceral 
leishmaniasis 
(skin; several 
organs) 
Vector (yes) Akhoundi et 
al., 2016; 
Stuart et al., 
2008 
Trypanosoma 
brucei 
(gambiense and 
rhodesiense) 
African 
trypanosomiasis / 
sleeping sickness 
(blood, 
lymphatics, 
brain) 
Vector (yes) Matthews, 
2015 
Trypanosoma 
cruzi 
Chagas disease 
(heart, systemic) 
Vector (yes) Messenger et 
al., 2015 
(yes ) = adopted to model 
 
 
Figure 1 Animal classes used in experiments for A: all life sciences disciplines in the 27 EU 
member states (2011 in %), and B: research on infection biology only, in Germany (2011 in 
%). Data taken from German Federal Ministry of Food and Agriculture, 2011. 
 
Figure 2 Number of citations with organism’s name in title (Dietrich et al., 2014), based on 
Web of Science entries for a given year. Numbers for single-celled model organisms like T.  
gondii, S. cerevisiae and E. coli are given for comparison. Green dashed line (with 
corresponding y-axis on the right) illustrates articles mentioning knock-out mice, with first 
papers appearing in the early 1990s. 
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Figure 3 Scheme explaining the principle of Collaborative Cross (CC) and Diversity Outbred 
(DO) sets (based on Chick et al., 2016). Initially, they all derived from 8 inbred founder 
strains. Chromosome 11 is given as an example, with the IRG locus (see 6.1) indicated by 
***. The locus is highly homogenous in 5 of the 8 founder strains (black ***) but highly 
polymorphic in the 3 wild-derived strains CAST, PWK and WSB, indicated by differently 
colored *** in the chromosomes.  
 
Figure 4 Names of rodents (with links in SI Table 2) to their available genome sequences at 
NCBI, together with their phylogenetic relationship (tree computed at 
https://www.ncbi.nlm.nih.gov/Taxonomy/CommonTree/wwwcmt.cgi) 
 
 
